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ABSTRACT
Congenital anomalies of the kidneys or lower urinary tract (CAKUT) are the most common causes of renal failure in
children and account for 25% of end-stage renal disease in adults. The spectrum of anomalies includes renal agenesis;
hypoplasia; dysplasia; supernumerary, ectopic or fused kidneys; duplication; ureteropelvic junction obstruction; primary
megaureter or ureterovesical junction obstruction; vesicoureteral reflux; ureterocele; and posterior urethral valves. CAKUT
originates from developmental defects and can occur in isolation or as part of other syndromes. In recent decades, along
with better understanding of the pathological features of the human congenital urinary tract defects, researchers using
animal models have provided valuable insights into the pathogenesis of these diseases. However, the genetic causes and
etiology of many CAKUT cases remain unknown, presenting challenges in finding effective treatment. Here we provide an
overview of the critical steps of normal development of the urinary system, followed by a description of the pathological
features of major types of CAKUT with respect to developmental mechanisms of their etiology.
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INTRODUCTION
The functioning unit of the kidney that produces urine is called
the nephron. For the purpose of this article, the proximal neph-
ron comprises the glomerulus, proximal tubules, loop of Henle
and distal tubules. The distal nephron harbors the collecting
system, mainly consisting of the collecting ducts. The filtrate,
namely urine, from the kidney is passed to the lower urinary
tract (ureter, bladder and urethra) for expulsion. Development
of the urinary system is a highly complex process that depends
on precise spatiotemporally regulated events and requires the
integration of a variety of progenitor cell populations of differ-
ent embryonic origins [1–3]. These events culminate in precise
anatomical connections between the proximal and distal neph-
rons in the kidney (upper tract) and the upper and lower urinary
tract. Most clinically relevant congenital anomalies of the kid-
neys or lower urinary tract (CAKUT) originate from the disrup-
tion of regulatory circuitry and the progenitor cells involved in
these processes, especially in the morphogenesis of the urinary
conduit or the functional aspects of the pyeloureteral peristaltic
machinery. The power of genetics and molecular biology in
model organisms has greatly advanced our knowledge that is
directly relevant to CAKUT in humans [4–9]. In this review we
will provide an overview of the major steps in nephrogenesis
and the development of the lower urinary tract. We will then
describe the pathological features of major types of CAKUT and
discuss the developmental pathology leading to CAKUT, based
on the evidence from human patients and animal disease mod-
els, especially murine models.
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NORMAL DEVELOPMENT OF THE KIDNEYS
AND THE URINARY TRACT
Development of the urinary system occurs in several stages in
mammals, culminating in a kidney and a ureter from each half
of the body, which are connected to the bladder. For simplicity
and to correlate the pathogenesis of CAKUT with specific devel-
opmental processes, we categorize the development of the kid-
ney and the urinary tract into the following stages [10, 11].
Preureteric bud induction andWolffian duct
morphogenesis
Most components of the urinary system are derived from the in-
termediate mesoderm [12] that give rise to the nephrogenic
cords at about 3weeks of gestation (wg) in humans and about
embryonic day 8 (E8) in mice. The nephrogenic cord produces
three sets of nephric structures: pronephros, mesonephros and
metanephros (Figure 1). Pronephros is the cranial most tran-
sient structure that emerges at about 3 wg in humans and
regresses by 4 wg (E9.5 in mice). Mesonephros development
coincides with pronephros regression and caudal extension of
the nephrogenic cord that metamorphoses into the mesoneph-
ric duct (Wolffian duct) and is surrounded by mesonephric mes-
enchyme. In mammals, the mesonephros is transient but
functional. In humans, the mesonephric tubules are linearly ar-
ranged along the Wolffian duct and are directly connected to it
(Figure 2). The Wolffian duct joins the cloaca (future bladder),
initiating the connection between the upper and lower urinary
tracts. In humans, the mesonephros regresses by 16 wg in a
caudal-to-cranial manner (by E11.5 in mice) except in males,
where the cranial most mesonephric tubules become the epi-
didymis and efferent ductules and the Wolffian duct becomes
the vas deferens. The precise regression of the mesonephroi is
critical for normal kidney development, and this process is reg-
ulated by signals in the Wolffian duct [13].
Ureteric bud induction
Metanephroi (definitive kidney) begin to form at 4.5 wg (and be-
come functional at 10 wg) in humans and E10.5 in mice.
Metanephric development starts with the outgrowth of epithe-
lial cells called the ureteric bud (UB) from the caudal Wolffian
duct. The UB invasion of the metanephric mesenchyme (MM),
in response to inductive signals from the MM, induces MM cells
to aggregate around the UB tip. This leads to branching of the
tip to form a T–shaped structure. The MM cells coalesce around
the branched tips to form the cap mesenchyme here after re-
ferred to as nephron progenitors. The UB tip cells are the pre-
cursors of the collecting ducts. This entire process is called UB
induction and indispensable for kidney formation. Thereafter
the UB undergoes repetitive branching to form the elaborate
collecting duct system through branching morphogenesis.
Branching morphogenesis
Branching morphogenesis requires reciprocal interactions among
the UB, MM, stromal cells and endothelial cells. UB tips proliferate
and branch to give rise to new UBs. The first few branches give rise
to the major and minor calyces in humans, into which the collect-
ing ducts from the respective papillae drain. All major calyces
drain into the pelvis, finally leading into the ureter. Branching
problems can cause decreased kidney mass (hypoplasia) and de-
fective structures (dysplasia). Nephrogenesis begins when mesen-
chyme cells coalesce near the junction of the UB stalk and the UB
tips and transition into pretubular aggregates. These cells undergo
a series of morphogenetic stages to form the proximal nephron,
consisting of the glomerulus, the proximal tubules, descending
and ascending loops of Henle, distal tubules and connecting
tubules. The endothelial progenitors invade the cleft at the distal
aspect of the S-shaped body along with the stromal cells to
become the glomerular capillaries and mesangium, respectively
[14–16]. Since the kidney grows in a centrifugal manner, the oldest
glomeruli are toward the cortico-medullary junction and the new-
est ones toward the periphery. Nephrogenesis completes before
birth in humans, but persists in early postnatal days in rodents. At
the end, the human kidney has multiple lobes, each comprising
the cortex, medulla and papillae that drain into minor and major
FIGURE 1: Illustration shows events in mammalian kidney development using
mouse stages as an example. Pronephros, the first stage, begins at about embry-
onic day 8 (E8) from intermediate cells. Mesonephros includes mesonephric
mesenchyme (MesM) and an epithelial tube called the Wolffian duct (WD). By
E10.5, the Wolffian duct has inserted into the cloaca, MesM is degenerating and
a bulge on the distal aspect of the WD develops into the UB that grows toward
the MM. The portion of the Wolffian duct distal to the UB is called the common
nephric duct (CND). At E11.5, the UB invades the MM, causing certain cells in the
MM to coalesce around the UB tips. These are called cap mesenchyme cells
(CaPM). Interactions between CaPM and UB and other cells in the MM initiate re-
cursive branching called branching morphogenesis. At E12.5, the ureter remod-
eling process starts to insert into the primitive bladder (UGS) and separate from
the Wolffian duct through a process of CND apoptosis (yellow).
FIGURE 2: Hematoxylin and eosin–stained section from a human fetus during
the mesonephros stage. Note the linearly arranged primitive glomeruli (arrows).
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calyces (Figure 3); mice have a single papilla that drains into the
pelvis. The peristaltic activity to propulse urine through the ureter
is initiated from pacemaker cells in the tips of the papillae.
Ascent and rotation
Concurrent to nephrogenesis, kidneys also undergo reposition-
ing through ascent and rotation. The kidneys grow posteriorly
(towards the back) during initial development. As development
progresses, they rotate anteromedially such that each hilum
points medially. Meanwhile, there is apparent ascent due to dis-
proportionate growth of the caudal regions of the embryo such
that the final position of the kidneys is retroperitoneal in the ab-
domen by 9 wg. The blood supply to the developing kidney is
initially via the caudal segments of the descending aorta or its
iliac branches. As the kidneys ascend, the blood supply is de-
rived from more cranial branches of the aorta while the caudal
vascular connections degenerate. The failure of regression of
transient blood vessels or sprouting of additional vessels to en-
sure adequate perfusion of the kidney may account for the vari-
ability seen in vascular supply to the kidney and accessory
renal arteries. In some cases, failure of regression of transient
vessels may compress the ureters, leading to hydronephrosis.
Ascent and rotation defects can also result in fusion or ectopic
kidneys.
Ureter maturation and bladder–urethra development
The initial stalk of the UB remains outside the MM, matures
into a ureter, elongates and connects to the bladder [10, 17, 18].
Common nephric duct is the part of the Wolffian duct distal to
the point where the ureter is initially attached to the Wolffian
duct (Figure 1). The initial Wolffian duct–cloaca contact occurs
before UB induction. After UB induction, the ureter separates
from the Wolffian duct through a process of ureteral remodeling
and maturation that leads to insertion of ureter into the blad-
der, the formation of a single lumen and separation of the
Wolffian duct from the ureter. The Wolffian duct inserts in the
urethra in males and degenerates in females. Ureteral smooth
muscle differentiation within the ureteral mesenchyme com-
mences at E14.5 in mice, following the establishment of a con-
nection between the Wolffian duct and bladder epithelium,
with the appearance of the first wave of a smooth muscle actin–
positive cells [19]. In humans, ureteral muscularization and de-
velopment of elastic fibers start at 12 wg [20–23]. Bladder epithe-
lium originates from the cloaca, a hindgut derivative with an
endodermal origin, in contrast to the mesodermal origin of the
kidney and the ureter epithelium from the Wolffian duct. Male
urethra develops as the urogenital sinus extends to the surface
of the genital tubercle.
PATHOLOGICAL AND CLINICAL FEATURES OF
CONGENITAL KIDNEY AND LOWER URINARY
TRACT DEFECTS
CAKUT is a term used broadly to describe developmental
defects in the urinary system that can occur in isolation, in
combination or as part of other syndromes. CAKUT comprises a
wide spectrum of congenital defects in the urinary system,
ranging from renal agenesis and hypoplasia, structural duplica-
tion and mispositioning to defects in the ureter and bladder.
Genetic, epigenetic and environmental factors can all cause
these abnormalities. The biology of CAKUT is further compli-
cated by the fact that affected family members may exhibit dif-
ferent types of CAKUT [7, 8, 24–29]. We will discuss the
clinicopathological features of the most common types of
CAKUT in relation to underlying developmental defects and
provide a summary of candidate genes, underlying CAKUT and
the likely developmental mechanisms contributing to the
CAKUT phenotype (Tables 1–3).
Duplication and supernumerary kidneys
In supernumerary kidneys, multiple UBs emerge separately and
grow into the MM [162, 163]. Partial duplication, often clinically
insignificant, can result from UB stalk bifurcation before invad-
ing the MM or prior to initial branching of the primary UB stalk
in the MM. In complete duplication, two UBs emerge from the
WD, resulting in two complete sets of kidneys and ureters that
may insert into the bladder separately (Figure 4). These kidneys
may appear fused due to their development in the same MM. In
>95% of such cases, the lower ureter will enter the bladder at its
normal location but tunnels through it abnormally, leading to
reflux [164]. The upper ureter inserts more distally, closer to the
reproductive tract or in the urethra and frequently results in an
ureterocele. The ureterocele often drains the upper kidney or
the upper pole of a duplex kidney. Due to obstruction or reflux,
both kidneys may show dysplasia or obstructive nephropathy.
These patients may present with hypertension, pain and kidney
failure. The incidence of duplication in a clinical setting is 1 in
125 and may be as high as 1 in 25 in postmortem cases [162].
The extra UBs could result from enhanced UB budding signals,
failure to repress extraneous budding or aborted regression of
mesonephric mesenchyme. For reasons still unknown, duplica-
tion is more common in women than in men (2:1) [162].
Agenesis
Failure of the kidneys to develop (agenesis) is frequently caused
by defective/delayed WD growth or UB induction. Renal agene-
sis can be unilateral (1/1000) or bilateral (1/10 000) [165]. Bilateral
agenesis is incompatible with life and is more common in males
[165]. During embryogenesis, kidney agenesis causes oligohy-
dramnios and abnormal lung development. Oligohydramnios or
ahydramnios during fetal development often presents as
Potters sequence: flat facial features, wide-set eyes, limb
FIGURE 3: Hematoxylin and eosin–stained section of human perinatal kidney at
low power shows organization into lobules (appear as bumps) with outer cortex
(darker colored outer layer), medulla and papillae that drain into calyces (cres-
cent-shaped white spaces).
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defects, prominent epicanthal folds, hypoplastic lungs and ab-
sent to malformed kidneys [166]. Isolated unilateral agenesis
may cause compensatory hypertrophy of the contralateral kid-
ney and is commonly detected during routine sonography
examinations. The incidence is equal in males and females but
higher on the left than on the right side. About 50–70% of unilat-
eral agenesis may exhibit other urogenital anomalies, including
dysplasia, ectopia, reflux and proteinuria, and may present with
hypertension. The term ‘solitary kidney’ is frequently used to
describe the absence of one kidney in living patients. Without
the advantage of serial radiological follow-up from early gesta-
tion, it is difficult to determine if agenesis in these patients is
due to complete lack of UB induction or due to involution of a
dysplastic kidney.
Hypoplasia
Hypoplasia refers to small kidneys with a decreased number of
nephrons due to reduced branching morphogenesis. These kid-
neys exhibit preserved architecture with normal organization into
cortex and medulla. Unilateral hypoplasia has an incidence of 1/
1000, whereas bilateral cases are less frequent (1/4000). Most
patients with bilateral hypoplasia develop end-stage renal disease
(ESRD) in mid or late childhood and have a higher probability of
developing hypertension [165]. Simple unilateral hypoplasia may
have no consequence. Hypoplasia may accompany renal artery
hypoplasia. Macroscopically they may exhibit oligomeganephro-
nia, decreased renal lobes and secondary glomerulosclerosis.
Dysplasia
Dysplastic kidneys have abnormal architectural organization,
immature nephrons, undifferentiated stroma and incomplete
branching [167]. The signaling cues orchestrating nephrogenesis
appear asynchronous and there is a loss of coordinated recipro-
cal interactions among the UB, MM and stroma during branch-
ing morphogenesis. Dysplastic kidneys can be small, normal in
size or slightly larger than healthy kidneys and may show cystic
changes. Dysplasia can be unilateral (1/4300 in multicystic
dysplastic kidneys and 1/1000 in dysplastic kidneys) or bilateral
(1/7500) [165, 167]. Bilateral dysplasia is incompatible with life.
Although definitive diagnosis of dysplasia requires histological
assessment, the clinical diagnosis is often made through ante-
natal ultrasound. Dysplasia can occur in a portion or the entire
kidney. Contralateral kidney defects may be as high as 50–70%
in patients with unilateral kidney dysplasia who may also have
other CAKUT phenotypes. The prognosis of unilateral dysplasia
is usually good if infections and hypertension are well man-
aged. Extreme forms of dysplasia or arrest in branching can re-
sult in involution of the kidney or rudiments, also known as
aplastic kidneys. Extremely aplastic kidneys may be undetect-
able on radiological exam, leading to the diagnoses of solitary
kidney or unilateral agenesis [168]. Microscopically the dysplas-
tic kidneys show blastema elements; fetal glomeruli; tubular,
glomerular or collecting duct cysts; smooth muscle collarettes
surrounding primitive collecting ducts and cartilage in 30% of
cases (Figure 5). Multicystic dysplasia is a form of abnormal
metanephric differentiation characterized by the presence of re-
nal cysts of varying size and the absence of a normal pelvicali-
ceal system. Multicystic dysplastic kidneys may persist without
noticeable change, increase in size or undergo spontaneous in-
volution [169–174]. Dysplasia can be caused by primary defects
in branching morphogenesis or secondary to reflux.
Position defects (horseshoe kidneys, renal ectopia and
malrotation)
Position defects occur when kidneys are displaced along the an-
terior–posterior axis in the abdomen or mediolaterally relative
to their normal location from the midline. Fusion or apposition
of the growing kidneys may occur with position defects and
may become clinically significant when there are associated
anomalies such as refluxing ureters emanating from the fused
kidneys leading to reflux nephropathy (RN). Most fusions occur
near the posterior end of the kidneys. The ascent of the fused
kidneys may be hindered by crossing blood vessels and other
tissues. Thus the fused kidneys may position lower than normal
Table 1. Summary of cause and treatment of lower urinary tract defects affecting kidney function
Defects Definition Etiology
Clinical presentation and
pathological features Diagnosis Current treatment
Posterior urethral
valves
Obstructing valve
leaflets at the pos-
terior urethra
Urogenital sinus and
trigone
malformation
Bilateral HN; VUR; spectrum
of renal demise; UTI
VCUG Endoscopic valve ablation
UPJ obstruction Ureteral obstruction
at the ureteropel-
vic junction
Atretic, narrow or
aperistatic proxi-
mal ureteral
segment
High-grade HN (pre- or
postnatal); UTI; flank
pain
Renal US; diuretic re-
nal scan; magnetic
resonance
urography
Pyeloplasty—open or
laparoscopic
UVJO Ureteral obstruction
at the UVJ
Atretic, narrow or
aperistatic distal
ureteral segment
High-grade HUN (pre- or
postnatal); UTI; flank
pain
Renal US; Diuretic
renal scan; mag-
netic resonance
urography
Ureteral reimplantation
with or without a mega-
ureter repair
Ureterocele Balloon dilation of
the distal ureter
Ureteral and urogen-
ital sinus
malformation
Ectopic location may result
in BOO; often associated
with complete ureteral
duplication
Renal US; diuretic re-
nal scan; VCUG;
magnetic reso-
nance urography
Ureterocele incision or
excision
VUR Vesicoureteral reflux Ureteral and urogen-
ital sinus
malformation
Pre- or post-natal HN; fe-
brile UTI
VCUG Observation versus surgical
repair (endoscopic injec-
tion or ureteral
reimplantation)
HN, hydronephrosis; HUN, hydroureteronephrosis; BOO, bladder outlet obstruction; US, ultrasound.
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Table 2. A subset of genetic factors involved in CAKUT and the suspected mechanism based largely on the study of animal models
Gene/allele
symbols Gene names and functions
Defects in human patients and an-
imal models Likely mechanism References
Ace Angiotensin-converting enzyme (en-
zyme-converting angiotensin I
to angiotensin II)
Ace/mice: hydronephrosis, renal
parenchymal atrophy
Defective pyeloureteral peristalsis
as a result of a ureter differentia-
tion defect, a urine concentra-
tion defect/polyuria or both
[19]
Adamts1 A disintegrin-like and metallopepti-
dase with thrombospondin type 1
motif, 1 (metallopeptidase)
Adamts1/mice: UPJO, hydro-
nephrosis, hydroureter, other
urogenital defects
Unclear. Excessive collagen deposit
was found at UPJ
[30]
Agt Angiotensinogen (precursor of the
peptide hormone angiotensin)
Agt/mice: hydronephrosis, renal
parenchymal atrophy
Defective pyeloureteral peristalsis [31, 32]
Agtr1a/b Angiotensin II receptor, type 1 (1a and
b) (G protein-coupled receptor)
Agtr1/ (1a and b)mice: partial
penetrance, hydronephrosis in
older mutants, renal parenchy-
mal atrophy
Urinary SMC developmental.
Defect, renal pelvis development
[33, 34]
Agtr2 Angiotensin II receptor, type 2 (G pro-
tein-coupled receptor)
Agtr2/mice: limited incidence of
hydronephrosis, megaureter, re-
nal parenchymal atrophy
Ectopic and duplicated UB [24, 35]
Aldh1a2 Aldehyde dehydrogenase family 1
member A2 (encodes Raldh2, an
enzyme in retinoic acid
synthesis)
Aldh1a2/mice rescued by mater-
nal retinoic acid: hydroureter
and hydronephrosis
Defects in ureter maturation, espe-
cially the insertion of the ureter
into the bladder
[36]
Aqp2 Aquaporin 2 (water channel) The cphmutants (Aqp2S256L/S256L)
have polyuria and hydronephro-
sis. Other Aqp2mutations also
cause renal damage resembling
obstructive nephropathy
Polyuria overwhelms the pyeloure-
teral peristaltic machinery
[37–39]
b-catenin Same as Ctnnb1 (adherens junction
protein, involved in Wnt
signaling)
Hoxb7-CreT/þ; b-catenin flox/floxmice:
hydroureter and hydronephrosis
Ectopic and supernumerary UB [40]
BMP4/Bmp4 Bone morphogenetic protein 4 (ligand
in the TGF-b superfamily)
BMP4mutations found in human
patients with anomalous kidney
development. Bmp4þ/mice:
hydronephrosis, hydroureter,
other urinary tract defects
Ectopic and supernumerary UB [41–43]
Bmp5 Bone morphogenetic protein 5 (Ligand
in the TGF-b superfamily)
Short ear (Bmp5/)mice have
hydroureter and hydronephrosis
Spatial constraints in the lower ab-
dominal cavity affect urinary
transfer
[44, 45]
Bmp7 Bone morphogenetic protein 7 (Ligand
in the TGF-b superfamily)
Renal dysplasia, hypoplasia,
hydronephrosis and other
defects are seen in mice defi-
cient for Bmp7
MM differentiation and growth [46, 47]
Bmpr1a Bone morphogenetic protein receptor,
type IA (serine/threonine–protein
kinase receptor)
Mice deficient for Bmpr1a in the UB
or the intermediate mesoderm
has renal dysplasia, hypoplasia
and other defects
Defective BMP signaling in progen-
itor populations
[48, 49]
CHRM3/
Chrom3
Cholinergic receptor, Muscarinic 3 (G
protein-coupled receptor)
A frameshift mutation found in
CHRM3 in familial congenital
bladder malformation associ-
ated with prune belly-like syn-
drome. Bladder distension in
Chrom3mutant mice, especially
in males
Defective detrusor contraction.
Present in renal epithelia and
bladder muscle with unknown
functions
[50, 51]
Dlgh1 Same as Dlg1, Disk-large homolog 1
(scaffolding protein)
Dlgh1/mice: prenatal hydro-
nephrosis, short ureter and
defects in the ureteral insertion
into the bladder
SM differentiation defect, ectopic
UB
[52, 53]
Emx2 Empty spiracles homeobox 2 (tran-
scription factor)
Mice deficient for Emx2 lack kid-
ney, ureter, gonads and genital
tracts
Defective of UB branching after it
invades MM
[54]
EYA1/Eya1 Eyes absent homolog 1 (transcription
factor)
Rare mutation in EYA1 found in
CAKUT patients. Eya/mice:
kidney agenesis
Absence or reduced Gdnf and six
expression
[55, 56]
(continued)
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Table 2. (continued)
Gene/allele
symbols Gene names and functions
Defects in human patients and an-
imal models Likely mechanism References
Etv4 and Etv5 Ets variants 4 and 5 (transcription
factors)
Etv4/; Etv5þ/mice: kidney agen-
esis and severe hypodisplasia.
Double homozygotes: complete
agenesis
Absence of Etv4 and 5 functions
downstream of Ret to promote
and control branching
[57]
Fcgr2b and
Pdcd1
Fc receptor, IgG, low affinity IIb and
programmed cell death 1 (cell sur-
face membrane protein of the
immunoglobulin superfamily)
Some Fcgr2b/; Pdcd1/mice:
hydronephrosis
Autoimmune against UPKIIIA [58]
Fgf8 Fibroblast growth factor (secreted
signaling protein)
Mice with MM-specific inactivation
of Fgf8 have renal agenesis and
hypoplasia
Defective MM differentiation [59, 60]
Fgfr2 Fibroblast growth factor receptor 2
(receptor tyrosine kinase)
Some Pax3-CreT/þ; Fgfr2flox/floxmice
have hydroureter
Supernumerary UB, abnormal ure-
ter connection
[61]
Foxc1 and c2 Forkhead box protein C1/C2 (tran-
scription factor)
Foxc1/ and Foxc1þ/, Foxc2þ/
mice: duplex kidney, ureter du-
plication, hydroureter,
hydronephrosis
Ectopic and supernumerary UB [62]
Foxd1 Forkhead box D1 (transcription
factor)
Foxd1/mice: kidney hypoplasia,
fusion, malrotation
Altered signaling in the stroma.
Disruption of a key role for renal
capsule during kidney
development
[63, 64]
FRAS1/Fras1 Fraser syndrome 1 (extracellular ma-
trix protein)
Mice deficient for Fras1 have renal
agenesis
Failure of UB to invade MM [65, 66]
FREM2 FRAS1-related extracellular matrix
protein 2 (extracellular matrix
protein)
Mutations in FREM2 found in
CAKUT patients
Likely similar to FRAS1/Fras1
mutations
[65]
Gata2 GATA-binding protein 2 (transcrip-
tion factor)
Gata2/mice (with YAC rescue of
hematopoietic defects): hydrour-
eter, hydronephrosis
Unclear [67]
GATA3/Gata3 GATA-binding protein 3 (transcrip-
tion factor)
GATA3mutations found in HDR
(hypoparathyroidism, sensori-
neural deafness, renal anomaly)
syndrome. Gata3/mice have
kidney agenesis
Defects in nephric duct extension [68, 69]
GDNF/Gdnf Glial cell-derived neurotrophic factor
(ligand for RET)
Mice deficient for Gdnf have renal
agenesis
UB induction defect [70–72]
GFRA1/Gfra1 GDNF family receptor a1 (glycosyl-
phosphatidylinositol (GPI)-
linked cell surface receptor for
GDNF)
Mice deficient for Gfra1 have renal
agenesis. Deletion of Gfra1 after
UB induction causes renal
hypoplasia
Defects in UB growth and branch-
ing morphogenesis
[73]
Gli3 Glioma-associated oncogene family
zinc finger 3 (transcription factor)
Mice deficient for Gli3 have renal
agenesis or malformed kidneys
Defective expression of key kidney
patterning genes
[74, 75]
Grem1 Gremlin 1 (extracellular BMP
antagonist)
Mice deficient for Grem1 have renal
agenesis
Excessive BMP signaling. Defects in
UB outgrowth
[76, 77]
HNF1b/Hnf1b Hepatocyte nuclear factor 1-b (tran-
scription factor)
Hnf1bmutant mice have severe
hypoplasia and other kidney
defects
Broad expression in developing
kidney and urinary tract. May af-
fect multiple processes, espe-
cially UB outgrowth and
branching
[55, 78–83]
Hoxa11, Hoxc11
and Hoxd11
Homeobox a11, c11 and d11 (tran-
scription factors)
Mice with different combination of
mutations in these genes have
various kidney and urinary tract
defects, including hypoplasia
and agenesis
UB induction defect and branching
morphogenesis defects
[84–86]
Hoxa13 and
Hoxd13
Homeobox a13 and d13 (transcrip-
tion factors)
Hoxa13þ/; Hoxd13/mice: UVJO,
hydronephrosis, hydroureter,
other urogenital defects
Patterning defects. May have ho-
meotic transformation
[87]
HPSE2 Heparanase 2 (enzyme that
degrades heparin sulfate
proteoglycans)
Mutations in HPSE2 cause urofacial
syndrome
Likely defects in the nerves con-
trolling urinary voiding
[88, 89]
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Table 2. (continued)
Gene/allele
symbols Gene names and functions
Defects in human patients and an-
imal models Likely mechanism References
Hspa4l Heat-shock protein 4 like
(chaperone?)
Some Hspa4l/mice have genetic
background-dependent
hydronephrosis
Unclear [90]
Id2 Inhibitor of DNA binding 2 Id2/ and Id2þ/mice have
hydronephrosis
UPJ development [91]
IL-9 Interleukin 9 (cytokine) Overexpressing IL-9 by its own pro-
moter in mice: hydronephrosis
Likely autoanitibodies against uri-
nary tract components
[92]
Kcnj1 Potassium inwardly rectifying channel,
subfamily J, member 1 also known
as Romk (ion channel)
Romk/mice: hydronephrosis, wa-
ter and electrolyte balance
problem
Unclear [93]
Isl1 Islet1 (transcription factor) Hoxb6-CreT/þ; Isl1flox/floxmice have
kidney agenesis, hypoplasia and
hydroureter
Abnormal UB elongation and
branching. Reduction of
expression
[94]
L1cam L1 cell adhesion molecule (transcrip-
tion factor)
L1cam/mice: hydroureter and
hydronephrosis
Ectopic UB [26]
Lim1 Same as Lhx1 – Lim homeobox pro-
tein 1 (transmembrane protein)
Hoxb7-CreT/þ; Lim1lz/floxmice (with
Lim1 deletion in the UB deriva-
tives): hydroureter and hydro-
nephrosis. Mice carrying
homozygous germline muta-
tions for Lim1 have renal
agenesis
Ureter differentiation. [95–97]
Mesonephros defects in WD
growth
Limp-2 (Lgp85) Same as Scarb2 (scavenger
receptor)
Limp-2/mice: kidney and ureter
duplication, UPJO, hydroureter
and hydronephrosis
Ectopic and supernumerary UB [98]
Mdm2 Murine double minute-2 (nuclear
phosphoprotein that binds p53)
Mice deficient forMdm2 in the UB
develop renal hypoplasia
Aberrant proliferation and apopto-
sis of UB cells
[99]
NFIA/Nfia Nuclear factor I/A (transcription
factor)
Nfiaþ/ and Nfia/mice: vesi-
coureteral reflux, hydronephro-
sis and hydroureter. Human
NFIAþ/ patients have similar
defects
Abnormal development of the UPJ
and UVJ
[100]
Osr1 Odd-skipped related 1 (transcription
factor)
Mice deficient for Osr1 have com-
plete renal agenesis
Establish of MM from intermediate
mesoderm
[101–103]
PAX2/Pax2 Paired box gene 2 (transcription
factor)
Pax21Neu/þmice: vesicoureteral
reflux. Other mutant alleles
also cause vesicoureteral
reflux in addition to renal
agenesis
Delay in urinary tract maturation
in the Pax21Neu/þmice
[104–111]
Pbx1 Pre-B-cell leukemia homeobox 1 (tran-
scription factor)
Kidney mispositioning, renal hy-
poplasia and renal agenesis
have been observed in mice defi-
cient for Pbx1
MM dysfunction [112]
Ppp3r1 Protein phosphatase 3. Same as calci-
neurin (serine/threonine protein
phosphatase)
The Pax3-CreT/þ; Cnb1flox/floxmice
(with calcineurin inactivation
in the metanephric and
ureteral mesenchyme): early
postnatal hydronephrosis
and hydroureter
Pyeloureteral peristaltic defect, de-
fect in urinary tract SMC
development
[113]
Ptprs and Ptprf Protein tyrosine phosphatase, receptor
type S & F (protein tyrosine
phosphatase)
Ptprs; Ptprf double-mutant have
hydronephrosis, hydroureter,
duplex system and ureterocele
Defects in ureter maturation [114]
Rara and Rarb2 Retinoic acid receptor a/retinoic acid re-
ceptor b 2 (nuclear receptors)
Rara/; Rarb2/mice have hydro-
nephrosis, hydroureter, vesi-
coureteral reflux
Defective differentiation of the MM [115]
Renin Same as Ren1 (enzyme in the ren-
nin–angiotension system)
Renin/mice: hydronephrosis, re-
nal parenchymal atrophy
Possibly by polyuria. It is also pos-
sible that the mutation disrupts
SM differentiation
[116]
RET/Ret Ret proto-oncogene (receptor tyro-
sine kinase, receptor for Gdnf)
Ret/mice: renal agenesis, defec-
tive WD insertion into the cloaca
UB initiation defect, distal WD
growth
[117–119]
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Table 2. (continued)
Gene/allele
symbols Gene names and functions
Defects in human patients and an-
imal models Likely mechanism References
Mice carrying Ret alleles with spe-
cific mutation of the key tyro-
sines: CAKUT (hydronephrosis,
hydroureter, vesicoureteral re-
flux, dysplasia, hypoplasia, du-
plication, agenesis)
Cell survival, proliferation, migra-
tion Wolffian duct patterning,
UB induction, ureteral
maturation
[13, 73, 120–
123, 124]
Mice overexpressing Ret in UB: ves-
icoureteral reflux
Ureter maturation defect [125]
ROBO2/Robo2 Roundabout homolog 2 (SLIT2
receptor)
Robo2/mice carrying ROBO2
mutations/variants have vesi-
coureteral reflux
Ectopic and supernumerary UB [126–128]
SALL1/Sall1 SAL-like 1 (transcription factor) Heterozygous mutations in SALL1
in cause Townes-Brocks syn-
drome with renal involvement.
Mice deficient for Sall1 have re-
nal agenesis or severe
dysgenesis
Disruption of UB initiation [129–131]
SIX1/Six1 SIX homeobox 1 (transcription
factor)
SIX1mutations cause certain types
of bronchio-oto-renal syndrome.
Mice deficient for Six1 lack
kidneys
Failure of UB invasion into MM [132, 133]
SIX2/Six2 SIX homeobox 2 (transcription
factor)
Mice deficient for Six2 have severe
renal hypoplasia
Premature and ectopic differentia-
tion of mesenchymal cells into
epithelia; depletion of the pro-
genitor cell population within
the MM
[43, 134, 135]
Shh Sonic hedgehog (secreted signaling
molecule)
Hoxb7-CreT/þ; Shhflox/floxmice (Shh/
 in UB derivatives): hydroureter
and hydronephrosis
Mesenchymal proliferation, SMC
differentiation
[136]
Slc12a1 Solute carrier family 12, member 1.
Same as Nkcc2 – (sodium–potas-
sium–chloride cotransporter)
Nkcc2/mice: polyuria and hydro-
nephrosis of varying severity
Possibly by polyuria overwhelming
the pyeloureteral peristaltic
machinery
[137]
Slit2 Slit homolog 2 (ROBO2 ligand) Slit2/mice: hydroureter and
hydronephrosis
Ectopic and supernumerary UB [126]
Smad4 MAD homolog 4 (TGF-b signal
transducer)
Bmp7-CreT/þ; Smad4flox/floxmice:
hydronephrosis
Defective MM differentiation [138, 139]
Tbx18-CreT/þ; Smad4flox/flox mice:
UPJO, hydroureter
Spry1 Sprouty homolog 1 (RTK/ERK
antagonist)
Spry1/mice: hydroureter and
hydronephrosis
Ectopic and supernumerary UB [140]
Spry2 Sprouty homolog 2 (RTK/ERK
antagonist)
Spry2/mice: renal agenesis,
hydroureter and hydronephrosis
Ectopic and supernumerary UB [141]
Tbx18 T-box transcription factor 18 (tran-
scription factor)
Tbx18/mice: hydronephrosis,
hydroureter and short ureters
Ureteral SM defects due to ureteric
mesenchyme differentiation
anomalies
[142]
Tensin Same as Tns1 (actin-binding
protein)
Tensin/mice: cystic and hydro-
nephrotic kidney at a few
months of age
Unclear. May involve cell–cell, cell–
matrix interaction
[143]
Tshz3 Teashirt zinc finger family member 3
(transcription factor)
Tshz3/mice: hydronephrosis and
hydronephrosis
Defects in ureteral SM
differentiation
[144]
UpkII Uroplakin II (glycolsylated trans-
membrane protein)
UpkII/mice: hydronephrosis,
hydroureter, vesicoureteral
reflux
Urothelial hyperplasia may block
the urinary path. Alternatively,
the urothelium defects may af-
fect SM development
[115]
UpkIIIA Uroplakin III (glycolsylated trans-
membrane protein)
UpkIII/mice: hydronephrosis,
hydroureter, vesicoureteral
reflux
Urothelial hyperplasia may block
the urinary path. Alternatively,
the urothelium defects may af-
fect SM development
[145]
Wnt4 Wingless-type MMTV integration site
family, member 4 (secreted signal-
ing protein)
Mice deficient forWnt4 have renal
agenesis and hypoplasia
Failure in mesenchymal to epithe-
lial transition
[146, 147]
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or even asymmetrically to one side of the body. The fusion may
also affect rotation of the kidney. These changes can lead to tor-
tuous ureters, predisposing to urinary tract obstruction and sub-
sequent kidney damage. Major subtypes of positional
anomalies include the following.
Horseshoe kidneys. Horseshoe kidneys are the most common
fusion abnormality (1/400), resulting from abnormal positioning
of the mesenchyme or the WDs. The fusion tends to affect the
normal ascent of the kidneys to the upper abdomen. The kidney
parenchyma may be histologically normal unless affected by re-
flux or obstruction during development.
Crossed fused renal ectopia. In this second most common posi-
tion anomaly (1/2000), the kidney has crossed the midline and
fused with the contralateral kidney. The crossed kidney is usu-
ally smaller compared with the orthotopic kidney.
Ectopia. Ectopic kidneys are not located in the renal fossa.
Ectopia can be simple (ipsilateral to the pelvis) or crossed (con-
tralateral to the ureter entry site into the bladder) [175]. This
could be due to defects in ascent or an abnormal UB budding
site. The incidence of simple ectopia in clinical settings is 1/
10 000, but it is much higher in autopsies (1/1000). Solitary
crossed renal ectopia is much rarer (1/1 500 000) and the ureter
crosses over and lies contralateral to its entry site into the blad-
der. Ectopia and fusion defects may coexist, such as in pelvic
horseshoe kidneys.
Malrotation. Malrotated kidneys are abnormally rotated along
their long axis. These could be due to a failure of medial rotation
during ascent. As a result, the hilum is often facing anteriorly.
The incidence rate is 1/500. Malrotated kidneys usually do not
cause any symptoms unless accompanied by other anomalies.
Hydronephrosis
Hydronephrosis is distension and dilatation of the renal pelvis
and calyces, usually caused by interruption of the free flow of
urine away from the kidney. Lower urinary tract defects may
block the urinary path or affect pyeloureteral peristalsis for ef-
fective urine transport, leading to hydronephrosis [176]. Defects
within the kidney, such as urine concentration problems, can
lead to severe polyuria that overwhelms the pyeloureteral peri-
stalsis, leading to eventual disruption of urinary flow.
Cystinuria can lead to kidney stones, which can both block
urine outflow and affect ureteral peristalsis, leading to obstruc-
tion [177–179]. Thus hydronephrosis is the outcome of direct
Table 2. (continued)
Gene/allele
symbols Gene names and functions
Defects in human patients and an-
imal models Likely mechanism References
Wnt9b Wingless-type MMTV integration site
family, member 9b (secreted sig-
naling protein)
Mice deficient forWnt9b have renal
agenesis and hypoplasia
Defective early inductive response
in MM
[148]
Wnt11 Wingless-type MMTV integration site
family, member 11 (secreted sig-
naling protein)
Mice deficient forWnt9b have renal
hypoplasia
Defects in branching
morphogenesis
[149]
There are many more genes than those listed involved in congenital anomalies of the kidney and urinary tract. The information presented in this table is not meant to
be complete but is an example of genes known to be involved in various types of kidney and urinary tract anomalies. We apologize to the many researchers whose
work is not cited in this table due to space constraints. SMC, smooth muscle cells; BMP, Bone morphogenetic protein; YAC, yeast artificial chromosome.
Table 3. Human gene mutations, associated syndromic and nonsyndromic CAKUT and potential developmental processes contributing to the
phenotype
CAKUT phenotype Developmental process affected Genes and genetic mechanism
Agenesis Wolffian duct growth, pre-UB
development
Autosomal dominant: LIM1, PAX2, PAX8, GATA3, EYA1, FOXC1, RET [5, 7, 8, 25,
150–157]
Ectopic ureters, du-
plex collecting
system, dysplasia
Maintaining single UB Autosomal dominant: RET, GDNF, ROBO2, LIM1, GATA3, EYA1, BMP4 [5, 7, 8, 25,
150–152, 154, 155]
Agenesis, hypoplasia UB induction Autosomal dominant: RET, GDNF, SALL1, SIX1 [5, 7, 8, 25, 150–152, 154]
Autosomal recessive: ITGA8 [158]
Hypoplasia,
dysplasia
Branching morphogenesis,
nephrogenesis
Autosomal dominant: RET, WT1, PAX2, GDNF, BMP7, SALL1, HNF1B, MKS1, MKS2,
BMP4, GLI3, SIX2, DHCR7, SIX1, SIX5, MYOG, DSTYK, WNT4, SOX17, UPK3A [5, 7, 8,
25, 150–157]
Autosomal recessive: FRAS1, FREM1, FREM2, ITGA8, AGT, AGTR1 [5, 7, 8, 25, 150–152]
Genomic disorders: 4P deletion, rare CNVs (16p13, 17q12, 22q11 and others) [159–
161]
X-linked: KAL1, GPC3 [5, 7, 8, 25, 150–152]
Ureter defects (vesi-
coureteral reflux,
UPJO, ureterocele)
Ureter maturation, Wolffian duct–
cloaca fusion
Autosomal dominant: RET, GREM1, EYA1, ROBO2, PAX2, UPK3A, NF1A, AT [5, 7, 8,
25, 150–157]
Genomic disorders: rare CNVs [159–161]
X-linked: AGTR2 [24, 35]
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and indirect effects of conditions affecting the urinary conduit
and is not a distinct disease entity by itself.
Obstructive nephropathy and obstructive uropathy
Persistence of hydronephrosis can result in tubular atrophy, in-
flammation and fibrosis (Figure 6) [180–182]. These pathological
changes are collectively referred to as ‘obstructive nephropathy’
and ‘obstructive uropathy’. These terms have similar meanings,
with slight emphasis on pathological changes within the kidney
(obstructive nephropathy) or with additional reference to in-
volvement of the lower urinary tract (obstructive uropathy).
Damage to kidney architecture and function by urinary tract ob-
struction is especially devastating to the developing kidneys.
Even mild prenatal urinary tract obstruction can greatly affect
the number of nephrons formed. Severe prenatal urinary tract
obstruction can lead to the arrest of kidney development and
total loss of its function. In fact, congenital obstructive nephrop-
athy is the most common cause of chronic kidney diseases in
the pediatric population. Elevated hydrostatic pressure associ-
ated with obstruction results in radial dilatation of the tubules
and ducts, leading to increased epithelial apoptosis and tubular
atrophy, and causes a reduction in the glomerular filtration
rate. Infiltration of immune cells has been frequently reported
as obstructive nephropathy progresses. Disruption of the renal
architecture usually correlates with the increased severity of fi-
brosis [183–185]. Complete obstruction of the urinary tract is rel-
atively rare, but when it happens, timely intervention to release
the obstruction is critical for preserving kidney function. Partial
obstruction is more common in the clinical setting and even
partial obstruction can lead to progressive obstructive
nephropathy, ESRD and mortality, especially when obstruction
is bilateral.
Ureteropelvic junction obstruction
Ureteropelvic junction obstruction (UPJO) is the junction be-
tween the kidney pelvis and the ureters. UPJO is defined as an
obstruction of urine flow through the UPJ, causing progressive
renal damage (Figure 7) [186, 187]. UPJ is a location where pro-
genitor cells of different embryonic origins coalesce to form the
ureter muscular layer. Due to its anatomical position and the
complexity of the integration of separate progenitor cell popula-
tions, UPJO accounts for 50% of all antenatal hydronephrosis
cases and is the most common cause of congenital obstructive
nephropathy [186, 187]. Approximately, 1/100 pregnancies show
fetal upper urinary tract dilation by ultrasound. Although most
of these dilatations resolve spontaneously, 1/500 remains clini-
cally significant. UPJO occurs far more frequently in males than
in females (3–4:1) and more frequently on the left side. Crossing
blood vessels in some patients can also cause UPJO. Currently
surgical intervention remains the only option for UPJO due to
intrinsic causes. In children, the procedure of choice is an
Anderson–Hynes dismembered pyeloplasty in which the
obstructed segment is resected and the remaining ureter is
reanastomosed.
Vesicoureteral reflux
Vesicoureteral reflux (VUR) is the retrograde flow of urine from
the bladder to the ureter [188]. VUR is generally diagnosed by
the retrograde flow of radioopaque contrast material during a
voiding cystourethrogram (VCUG) (Figure 8) [189, 190]. VUR has
been observed in 0.1–1% of children [191–193]. This may be
underestimated due to limited use of the invasive VCUG [194].
Although many patients with VUR show no kidney injury, other
VUR patients develop RN, with pathological changes in ad-
vanced stages similar to obstructive nephropathy. As much as
8% of ESRD may be caused by VUR [188]. The pathophysiology of
RN may be different than obstructive nephropathy, and early
stages show segmental scarring of the renal parenchyma due to
the propensity of reflux to damage superior and inferior lobes of
the kidney. This is because these regions have compound papil-
lae with a round orifice that facilitates retrograde flow. If
untreated, the adjacent simple papillae transform into com-
pound papillae and gradually affect the entire kidney. The
scarred regions show thinning of the overlying cortex. If VUR is
the only urinary tract anomaly found, then it is referred to as
primary VUR. VUR is often associated with, and likely secondary
to, other types of urinary tract defects, such as neurogenic blad-
der, posterior urethral valves (PUV) or ureterocele [195–197].
VUR can also occur as part of extrarenal syndromes [194]. VUR
is frequently associated with urinary tract infection (UTI). UTIs
in the setting of VUR may affect kidney function by providing
access to bacteria from the bladder into the ureter and kidney
and causing scarring (RN). By VCUG, 25–40% of screened chil-
dren with UTI have VUR [198].
Ureterovesical junction obstruction and hydroureter
The ureterovesical junction (UVJ) is the site where the ureter
enters the bladder. Back pressure associated with physical ob-
struction at the UVJ usually causes dilatation of the ureter
(hydroureter or megaureter) and eventually hydronephrosis.
Although less common than UPJO, persistent UVJ obstruction
(UVJO) is as damaging to kidney function as UPJO. UVJO can be
FIGURE 4: VCUG depicts complete duplication of the urinary system. The pri-
mary ureter (ureter1) inserts higher in the bladder and drains the lower kidney
(kidney1). The dilated ureter2 inserts much lower in the bladder and drains the
upper kidney (kidney2). Duplication can arise from failure to repress ectopic
budding from the Wolffian duct or multiple UB inductions during metanephros
development.
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caused by a poorly peristalsing ureteral segment near the blad-
der, abnormal insertion of the ureter into the bladder, a short
intravesical ureteral segment, infection, scar tissues, kidney
stones and other factors. If an obstructed segment or anatomic
ureteral anomalies are present, then resection of the affected
segment and refitting the ureter into the bladder is the current
treatment option.
Ureterocele, ectopic ureter and duplicated ureter
Ureterocele is a saccular dilation of the terminal portion of the
ureter inside the bladder (Figure 9) [176, 199]. The clinical effects
of ureteroceles range from being asymptomatic to causing uri-
nary tract obstruction and kidney damage. The normal site of
ureter entry into the bladder is near the base of the bladder. The
bladder trigone (a thickened muscular pad on the back of the
bladder) helps to secure the intravesical segment of the ureter
to prevent kinking and reflux. An abnormal ureter entry site
and angle tend to nullify the function of the trigone, leading to
reflux or obstruction. In rare cases, the distal ureter connects to
the reproductive organs, such as the uterus, the vagina or the
FIGURE 5: Renal dysplasia. (A) Gross morphology of cystic dysplastic kidneys. The image on the left shows the irregular shape of the entire kidney and the image on
the right is the cut surface showing multiple cysts and no organization. (B) Histology of renal dysplasia. Both images show no normal renal structures or organization
into cortex, medulla and papillae. Numerous cysts are scattered in the kidney. The image on the left highlights collecting ducts in the center surrounded by concentric
immature mesenchymal cells (arrows). The image on the right additionally has cartilage (white arrow) in the center that can be seen in about a third of dysplastic kid-
neys. Dysplasia can arise from abnormal UB budding or branching morphogenesis and nephrogenesis.
FIGURE 6: Obstructive nephropathy. Hematoxylin and eosin–stained section of a
kidney from a patient with long-standing urinary tract obstruction shows signifi-
cant kidney damage. Note that several tubules are dilated with no epithelial lining,
thus showing atrophy (arrows). A number of the tubules show proteinaceous eo-
sinophilic material representative of end-stage nephrons. Also note the intense in-
flammatory infiltrate involving almost the entire parenchyma.
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epididymis [200–203]. The resulting fistulae between the ureter
and the reproductive organs tend to be obstructed, leading to
hydroureter, hydronephrosis and kidney damage.
Bladder outlet obstruction and posterior urethral valves
Bladder outlet obstruction is the blockage of urine passage from
the bladder to the urethra caused by benign prostate hyperpla-
sia, bladder tumor, bladder stones, PUV or other causes. PUV, a
congenital blockage of the posterior urethra [204, 205], is a com-
mon cause of urinary tract obstruction in male infants, with an
estimated incidence rate of 1/5000–8000 male births and may
account for 10% of all prenatally detected hydronephrosis [206–
208]. PUVs can cause bilateral kidney damage, kidney failure
and even death. It is one of the leading causes of kidney failure
in children. PUV is typically detected by prenatal ultrasound
and subsequently diagnosed definitively after birth. Fetuses
with PUV can have bilateral hydroureter/hydronephrosis with a
thick trabeculated bladder wall and keyhole sign in the bladder
neck (Figure 10). A VCUG and/or cystoscopic evaluation can be
FIGURE 8: Vesicoureteral reflux (VUR). Vesicoureterocystogram shows high-
grade (Grade 5) VUR. Note the dilated, tortuous ureter, with reflux involving the
kidney parenchyma, highlighted by the white dye almost spanning each kidney.
Primary VUR is due to abnormal development of the ureterovesicle junction so
that the valve mechanism to prevent reflux from the bladder into the ureter
does not function normally.
FIGURE 9: Ureterocele. The lower abdominal and pelvic ultrasonograph shows a
ureterocele (arrow). Note the clear blind ending ureterocele lining (arrow) con-
nected to the dilated ureter (long hypoechogenic tube).
FIGURE 10: Posterior uretheral valves (PUV). The radiograph shows classic find-
ings of PUV in a male child. Note the extreme narrowing of the urethra (arrow)
due to persistent valves that lead to a dilated bladder with irregular surface
(trabeculations).
FIGURE 7: Hydronephrosis and obstruction. The radiographic image shows dif-
fuse dilation of the collecting system with dilated pelvis (arrow) due to lower
urinary tract obstruction. Obstruction can result from functional or physical ab-
normalities that are intrinsic or extrinsic to the urinary system.
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used to demonstrate the presence of the ‘valves’ or ‘mem-
branes’ that block urine passage. Although a bladder catheter
can provide immediate relief, endoscopic ablation can be per-
formed to permanently correct the defects.
CONCLUSIONS
A prominent feature of the development of the urinary system
is the dynamic temporal and spatial integration of progenitor
tissues of distinct embryonic origins. Such integration requires
precise control of proliferation, apoptosis, migration and differ-
entiation of all the progenitor cells involved to create junctional
complexes, which if malformed result in bottlenecks for urine
passage [9]. Research in animal models, especially transgenic
mouse models, has contributed to a better understanding of the
genetic factors and mechanisms of the pathogenesis of CAKUT
(Table 2) that help us understand the genotype–phenotype asso-
ciation and mechanism in CAKUT patients (Table 3). Of note,
many CAKUT cases have a developmental basis even before the
metanephric kidney begins to develop. A deeper understanding
of the embryonic processes underlying normal and abnormal
development of the urinary tract will inform potential target-
able therapies with small molecules and provide necessary
knowledge to build kidneys that can be transplanted into
patients. Genetic studies have taught us that CAKUT is a geneti-
cally heterogeneous disorder and the phenotype is influenced
by gene interactions and epigenetic pathways. A major chal-
lenge in patient care is determining the pathogenicity of poten-
tially deleterious variants identified in patients. Advances in
the field of genome editing and induced pluripotent cell-derived
kidney organoids will surely overcome this hurdle in the near
future and ultimately bring precision medicine to patients with
CAKUT.
ACKNOWLEDGEMENTS
We thank Dr Helen Liapis and Paul Austin for constructive
suggestions and other contributions.
FUNDING
F.C. is supported in part by National Institutes of Health
grants HG009711, CA224083 and CA180006. S.J. is supported
in part by R01DK082531.
CONFLICT OF INTEREST STATEMENT
None declared. The content presented in this article has not
been published previously in whole or part.
REFERENCES
1. Little MH, McMahon AP. Mammalian kidney development:
principles, progress, and projections. Cold Spring Harb
Perspect Biol 2012; 4: a008300
2. Faa G, Gerosa C, Fanni C et al. Morphogenesis andmolecular
mechanisms involved in human kidney development. J Cell
Physiol 2012; 227: 1257–1268
3. Saxen L. Inductive interactions in kidney development.
Symp Soc Exp Biol 1971; 25: 207–221
4. Weber S. Novel genetic aspects of congenital anomalies of
kidney and urinary tract. Curr Opin Pediatr 2012; 24: 212–218
5. Renkema KY, Winyard PJ, Skovorodkin IN et al. Novel per-
spectives for investigating congenital anomalies of the
kidney and urinary tract (CAKUT). Nephrol Dial Transplant
2011; 26: 3843–3851
6. Song R, Yosypiv IV. Genetics of congenital anomalies of the
kidney and urinary tract. Pediatr Nephrol 2011; 26: 353–364
7. Nakanishi K, Yoshikawa N. Genetic disorders of human
congenital anomalies of the kidney and urinary tract
(CAKUT). Pediatr Int 2003; 45: 610–616
8. Ichikawa I, Kuwayama F, Pope JC et al. Paradigm shift from
classic anatomic theories to contemporary cell biological
views of CAKUT. Kidney Int 2002; 61: 889–898
9. Chen F. Genetic and developmental basis for urinary tract
obstruction. Pediatr Nephrol 2009; 24: 1621–1632
10. Schedl A. Renal abnormalities and their developmental ori-
gin.Nat Rev Genet 2007; 8: 791–802
11. Jain S. Overview of congenital anomalies of the kidney and uri-
nary tract. In: Colvin RB, Chang AC (eds.). Diagnostic
Pathology: Kidney Diseases, 2nd edn. Philadelphia:
Elsevier, 2016, 828–831
12. Dressler GR. Advances in early kidney specification, devel-
opment and patterning. Development 2009; 136: 3863–3874
13. Hoshi M, Batourina E, Mendelsohn C et al. Novel mecha-
nisms of early upper and lower urinary tract patterning
regulated by RetY1015 docking tyrosine in mice.
Development. 2012; 139: 2405–2415
14. Kreidberg JA. Podocyte differentiation and glomerulogene-
sis. J Am Soc Nephrol 2003; 14: 806–814
15. Miner JH. Organogenesis of the kidney glomerulus: focus
on the glomerular basement membrane. Organogenesis
2011; 7: 75–82
16. Quaggin SE, Kreidberg JA. Development of the renal glo-
merulus: good neighbors and good fences. Development
2008; 135: 609–620
17. Dressler GR. The cellular basis of kidney development.
Annu Rev Cell Dev Biol 2006; 22: 509–529
18. Costantini F, Shakya R. GDNF/Ret signaling and the devel-
opment of the kidney. Bioessays 2006; 28: 117–127
19. Esther CR Jr, Howard TE, Marino EM et al. Mice lacking
angiotensin-converting enzyme have low blood pressure,
renal pathology, and reduced male fertility. Lab Invest 1996;
74: 953–965
20. Baker LA, Gomez RA. Embryonic development of the ureter.
Semin Nephrol 1998; 18: 569–584
21. Baker LA, Gomez RA. Embryonic development of the ureter
and bladder: acquisition of smooth muscle. J Urol 1998; 160:
545–550
22. Matsuno T, Tokunaka S, Koyanagi T. Muscular develop-
ment in the urinary tract. J Urol 1984; 132: 148–152
23. Escala JM, Keating MA, Boyd G et al. Development of elastic
fibres in the upper urinary tract. J Urol 1989; 141: 969–973
24. Nishimura H, Yerkes E, Hohenfellner K et al. Role of the an-
giotensin type 2 receptor gene in congenital anomalies of
the kidney and urinary tract, CAKUT, of mice and men.Mol
Cell 1999; 3: 1–10
25. Pope JC, Brock JW, AdamsMC et al. How they begin and how
they end: classic and new theories for the development
and deterioration of congenital anomalies of the kidney
and urinary tract, CAKUT. J Am Soc Nephrol 1999; 10:
2018–2028
26. Debiec H, Kutsche M, Schachner M et al. Abnormal renal
phenotype in L1 knockout mice: a novel cause of CAKUT.
Nephrol Dial Transplant 2002; 17(Suppl 9): 42–44
27. Miyazaki Y, Ichikawa I. Ontogeny of congenital anomalies
of the kidney and urinary tract, CAKUT. Pediatr Int 2003; 45:
598–604
394 | S. Jain and F. Chen
D
ow
nloaded from
 https://academ
ic.oup.com
/ckj/article-abstract/12/3/382/5224972 by W
ashington U
niversity, Law
 School Library user on 15 N
ovem
ber 2019
28. Nakai H, Asanuma H, Shishido S et al. Changing concepts in
urological management of the congenital anomalies of kid-
ney and urinary tract, CAKUT. Pediatr Int 2003; 45: 634–641
29. Stahl DA, Koul HK, Chacko JK et al. Congenital anomalies of
the kidney and urinary tract (CAKUT): a current review of
cell signaling processes in ureteral development. J Pediatr
Urol 2006; 2: 2–9
30. Shindo T, Kurihara H, Kuno K et al. ADAMTS-1: a
metalloproteinase-disintegrin essential for normal growth,
fertility, and organ morphology and function. J Clin Invest
2000; 105: 1345–1352
31. Nagata M, Tanimoto K, Fukamizu A et al. Nephrogenesis
and renovascular development in angiotensinogen-
deficient mice. Lab Invest 1996; 75: 745–753
32. Niimura F, Labosky PA, Kakuchi J et al. Gene targeting in
mice reveals a requirement for angiotensin in the develop-
ment and maintenance of kidney morphology and growth
factor regulation. J Clin Invest 1995; 96: 2947–2954
33. Oliverio MI, Kim HS, Ito M et al. Reduced growth, abnormal
kidney structure, and type 2 (AT2) angiotensin receptor-
mediated blood pressure regulation in mice lacking both
AT1A and AT1B receptors for angiotensin II. Proc Natl Acad
Sci USA 1998; 95: 15496–15501
34. Miyazaki Y, Tsuchida S, Nishimura H et al. Angiotensin
induces the urinary peristaltic machinery during the peri-
natal period. J Clin Invest 1998; 102: 1489–1497.
35. Oshima K, Miyazaki Y, Brock JW et al. Angiotensin type II re-
ceptor expression and ureteral budding. J Urol 2001; 166:
1848–1852
36. Batourina K, Tsai S, Lambert S et al. Apoptosis induced by
vitamin A signaling is crucial for connecting the ureters to
the bladder. Nat Genet 2005; 37: 1082–1089
37. McDill BW, Li SZ, Kovach PA et al. Congenital progressive
hydronephrosis (CPH) is caused by an S256L mutation in
aquaporin-2 that affects its phosphorylation and apical
membrane accumulation. Proc Natl Acad Sci USA 2006; 103:
6952–6957
38. Yang B, Gillespie A, Carlson EJ et al. Neonatal mortality in
an aquaporin-2 knock-in mouse model of recessive neph-
rogenic diabetes insipidus. J Biol Chem 2001; 276: 2775–2779
39. Lloyd DJ, Hall FW, Tarantino LM et al. Diabetes insipidus in
micewith amutation in aquaporin-2. PLoS Genet 2005; 1: e20
40. Marose TD, Merkel CE, McMahon AP et al. Beta-catenin is
necessary to keep cells of ureteric bud/Wolffian duct epi-
thelium in a precursor state. Dev Biol 2008; 314: 112–126
41. Dunn NR, Winnier GE, Hargett LK et al. Haploinsufficient
phenotypes in Bmp4 heterozygous null mice and modifica-
tion by mutations in Gli3 and Alx4. Dev Biol 1997; 188:
235–247
42. Miyazaki Y, Oshima K, Fogo A et al. Bone morphogenetic
protein 4 regulates the budding site and elongation of the
mouse ureter. J Clin Invest 2000; 105: 863–873
43. Weber S, Taylor JC, Winyard P et al. SIX2 and BMP4 muta-
tions associate with anomalous kidney development. J Am
Soc Nephrol 2008; 19: 891–903
44. Green M. Further morphological effects of the short ear
gene in the housemouse. J Morphol 1951; 88: 1–22
45. King JA, Marker PC, Seung KJ et al. BMP5 and the molecular,
skeletal, and soft-tissue alterations in short ear mice. Dev
Biol 1994; 166: 112–122
46. Dudley AT, Lyons KM, Robertson EJ. A requirement for bone
morphogenetic protein-7 during development of the mam-
malian kidney and eye. Genes Dev 1995; 9: 2795–2807
47. Luo G, Hofmann C, Bronckers AL et al. BMP-7 is an inducer
of nephrogenesis, and is also required for eye development
and skeletal patterning. Genes Dev 1995; 9: 2808–2820
48. Hartwig S, Bridgewater D, Di Giovanni V et al. BMP receptor
ALK3 controls collecting system development. J Am Soc
Nephrol 2008; 19: 117–124
49. Di Giovanni V, Alday A, Chi L et al. Alk3 controls nephron
number and androgen production via lineage-specific
effects in intermediate mesoderm. Development 2011; 138:
2717–2727
50. Weber S, Thiele H, Mir S et al. Muscarinic acetylcholine re-
ceptor M3 mutation causes urinary bladder disease and a
prune-belly-like syndrome. Am J Hum Genet 2011; 89:
668–674
51. Matsui M, Motomura D, Karasawa H et al. Multiple func-
tional defects in peripheral autonomic organs in mice lack-
ing muscarinic acetylcholine receptor gene for the M3
subtype. Proc Natl Acad Sci USA 2000; 97: 9579–9584
52. Mahoney ZH, Sammut B, Xavier RJ et al. Discs-large homo-
log 1 regulates smooth muscle orientation in the mouse
ureter. Proc Natl Acad Sci USA 2006; 103: 19872–19877
53. Iizuka-Kogo A, Ishidao T, Akiyama T et al. Abnormal devel-
opment of urogenital organs in Dlgh1-deficient mice.
Development 2007; 134: 1799–1807
54. Miyamoto N, Yoshida M, Kuratani S et al. Defects of urogen-
ital development in mice lacking Emx2. Development 1997;
124: 1653–1664
55. Hoskins BE, Cramer CH, Tasic V, et al. Missense mutations
in EYA1 and TCF2 are a rare cause of urinary tract malfor-
mations.Nephrol Dial Transplant 2008; 23: 777–779
56. Xu PX, Adams J, Peters H et al. Eya1-deficient mice lack ears
and kidneys and show abnormal apoptosis of organ pri-
mordia. Nat Genet 1999; 23: 113–117
57. Lu BC, Cebrian C, Chi X et al. Etv4 and Etv5 are required
downstream of GDNF and Ret for kidney branching mor-
phogenesis. Nat Genet 2009; 41: 1295–1302
58. Okazaki T, Otaka Y, Wang J et al. Hydronephrosis associated
with antiurothelial and antinuclear autoantibodies in BALB/
c-Fcgr2b/Pdcd1/mice. J ExpMed 2005; 202: 1643–1648
59. Grieshammer U, Cebrian C, Ilagan R et al. FGF8 is required
for cell survival at distinct stages of nephrogenesis and for
regulation of gene expression in nascent nephrons.
Development 2005; 132: 3847–3857
60. Perantoni AO, Timofeeva O, Naillat F et al. Inactivation of
FGF8 in early mesoderm reveals an essential role in kidney
development. Development 2005; 132: 3859–3871
61. Hains D, Sims-Lucas S, Kish K et al. Role of fibroblast growth
factor receptor 2 in kidney mesenchyme. Pediatr Res 2008;
64: 592–598
62. Kume T, Deng K, Hogan BL. Murine forkhead/winged helix
genes Foxc1 (Mf1) and Foxc2 (Mfh1) are required for the
early organogenesis of the kidney and urinary tract.
Development 2000; 127: 1387–1395
63. Hatini V, Huh SO, Herzlinger D, et al. Essential role of stro-
mal mesenchyme in kidney morphogenesis revealed by
targeted disruption of Winged Helix transcription factor
BF-2. Genes Dev 1996; 10: 1467–1478
64. Levinson RS, Batourina E, Choi C et al. Foxd1-dependent sig-
nals control cellularity in the renal capsule, a structure re-
quired for normal renal development. Development 2005;
132: 529–539
65. Saisawat P, Tasic V, Vega-Warner V. Identification of two
novel CAKUT-causing genes by massively parallel exon
Developmental pathology CAKUT | 395
D
ow
nloaded from
 https://academ
ic.oup.com
/ckj/article-abstract/12/3/382/5224972 by W
ashington U
niversity, Law
 School Library user on 15 N
ovem
ber 2019
resequencing of candidate genes in patients with unilateral
renal agenesis. Kidney Int 2011; 81: 196–200
66. Pitera JE, Scambler PJ, Woolf AS. Fras1, a basement
membrane-associated protein mutated in Fraser syn-
drome, mediates both the initiation of the mammalian kid-
ney and the integrity of renal glomeruli. Hum Mol Genet
2008; 17: 3953–3964
67. Zhou Y, Lim KC, Onodera K. Rescue of the embryonic lethal
hematopoietic defect reveals a critical role for GATA-2 in
urogenital development. EMBO J 1998; 17: 6689–6700
68. Van Esch H, Groenen P, Nesbit MA et al. GATA3 haplo-
insufficiency causes human HDR syndrome. Nature 2000;
406: 419–422
69. Grote D, Boualia SK, Souabni A et al. Gata3 acts downstream
of beta-catenin signaling to prevent ectopic metanephric
kidney induction. PLoS Genet 2008; 4: e1000316
70. Sanchez MP, Silos-Santiago I, Frisen J et al. Renal agenesis
and the absence of enteric neurons in mice lacking GDNF.
Nature 1996; 382: 70–73
71. Pichel JG, Shen L, Sheng HZ, et al. Defects in enteric innerva-
tion and kidney development in mice lacking GDNF. Nature
1996; 382: 73–76
72. Moore MW, Klein RD, Fari~nas I et al. Renal and neuronal ab-
normalities inmice lacking GDNF.Nature 1996; 382: 76–79
73. Keefe Davis T, Hoshi M, Jain S. Stage specific requirement
of Gfra1 in the ureteric epithelium during kidney develop-
ment.Mech Dev 2013; 130; 506–518
74. Hu MC, Mo R, Bhella S et al. GLI3-dependent transcriptional
repression of Gli1, Gli2 and kidney patterning genes dis-
rupts renal morphogenesis. Development 2006; 133: 569–578
75. Bose J, Grotewold L, Ruther U. Pallister-Hall syndrome phe-
notype in mice mutant for Gli3. Hum Mol Genet 2002; 11:
1129–1135
76. Michos O, Panman L, Vintersten K et al. Gremlin-mediated
BMP antagonism induces the epithelial-mesenchymal
feedback signaling controlling metanephric kidney and
limb organogenesis. Development 2004; 131: 3401–3410
77. Michos O, Gonc¸alves A, Lopez-Rios J et al. Reduction of
BMP4 activity by gremlin 1 enables ureteric bud outgrowth
and GDNF/WNT11 feedback signalling during kidney
branching morphogenesis. Development 2007; 134:
2397–2405
78. Bingham C, Ellard S, Cole TRP et al. Solitary functioning kid-
ney and diverse genital tract malformations associated
with hepatocyte nuclear factor-1b mutations. Kidney Int
2002; 61: 1243–1251
79. Bingham C, Bulman MP, Ellard S et al. Mutations in the he-
patocyte nuclear factor-1b gene are associated with famil-
ial hypoplastic glomerulocystic kidney disease. Am J Hum
Genet 2001; 68: 219–224
80. Bingham C, Ellard S, Allen L et al. Abnormal nephron devel-
opment associated with a frameshift mutation in the tran-
scription factor hepatocyte nuclear factor-1 b. Kidney Int
2000; 57: 898–907
81. Lindner TH, Njolstad PR, Horikawa Y et al. A novel syn-
drome of diabetes mellitus, renal dysfunction and genital
malformation associated with a partial deletion of the
pseudo-POU domain of hepatocyte nuclear factor-1b. Hum
Mol Genet 1999; 8: 2001–2008
82. Kolatsi-Joannou M, Bingham C, Ellard S. Hepatocyte nu-
clear factor-1b: a new kindred with renal cysts and diabetes
and gene expression in normal human development. J Am
Soc Nephrol 2001; 12: 2175–2180
83. Lokmane L, Heliot C, Garcia-Villalba P et al. vHNF1 func-
tions in distinct regulatory circuits to control ureteric bud
branching and early nephrogenesis. Development 2010; 137:
347–357
84. Wellik DM, Hawkes PJ, Capecchi MR. Hox11 paralogous
genes are essential for metanephric kidney induction.
Genes Dev 2002; 16: 1423–1432
85. Patterson LT, Pembaur M, Potter SS. Hoxa11 and Hoxd11
regulate branching morphogenesis of the ureteric bud in
the developing kidney. Development 2001; 128: 2153–2161
86. Mugford JW, Sipila P, Kobayashi A et al. Hoxd11 specifies a
program of metanephric kidney development within the
intermediate mesoderm of the mouse embryo. Dev Biol
2008; 319: 396–405
87. Warot X, Fromental-Ramain C, Fraulob V et al. Gene
dosage-dependent effects of the Hoxa-13 and Hoxd-13
mutations on morphogenesis of the terminal parts of the
digestive and urogenital tracts. Development 1997; 124:
4781–4791
88. Daly SB, Urquhart JE, Hilton E et al. Mutations in
HPSE2 cause urofacial syndrome. Am J Hum Genet 2010; 86:
963–969
89. Guo C, Kaneko S, Sun Y et al. A mouse model of urofacial
syndrome with dysfunctional urination. Hum Mol Genet
2015; 24: 1991–1999
90. Held T, Paprotta I, Khulan J et al. Hspa4l-deficient mice dis-
play increased incidence of male infertility and hydroneph-
rosis development.Mol Cell Biol 2006; 26: 8099–8108
91. Aoki Y, Mori S, Kitajima K et al. Id2 haploinsufficiency in
mice leads to congenital hydronephrosis resembling that
in humans. Genes Cells 2004; 9: 1287–1296
92. Lauder AJ, Jolin HE, Smith P et al. Lymphomagenesis, hydro-
nephrosis, and autoantibodies result from dysregulation of
IL-9 and are differentially dependent on Th2 cytokines.
J Immunol 2004; 173: 113–122
93. Lorenz JN, Baird NR, Judd LM et al. Impaired renal NaCl ab-
sorption in mice lacking the ROMK potassium channel, a
model for type II Bartter’s syndrome. J Biol Chem 2002; 277:
37871–37880
94. Kaku Y, Ohmori T, Kudo K et al. Islet1 deletion causes kid-
ney agenesis and hydroureter resembling CAKUT. J Am Soc
Nephrol 2013; 24: 1242–1249
95. Shawlot W, Behringer RR. Requirement for Lim1 in head-
organizer function. Nature 1995; 374: 425–430
96. Tsang TE, Shawlot W, Kinder SJ et al. Lim1 activity is re-
quired for intermediate mesoderm differentiation in the
mouse embryo. Dev Biol 2000; 223: 77–90
97. Kobayashi A, Kwan KM, Carroll TJ et al. Distinct and se-
quential tissue-specific activities of the LIM-class homeo-
box gene Lim1 for tubular morphogenesis during kidney
development. Development 2005; 132: 2809–2823
98. GampAC, Tanaka Y, Lullmann-Rauch R. LIMP-2/LGP85 defi-
ciency causes ureteric pelvic junction obstruction, deafness
and peripheral neuropathy in mice. HumMol Genet 2003; 12:
631–646
99. Hilliard S, Aboudehen K, Yao X et al. Tight regulation of p53
activity by Mdm2 is required for ureteric bud growth and
branching. Dev Biol 2011; 353: 354–366
100. Lu W, Quintero-Rivera F, Fan Y et al. NFIA haploinsuffi-
ciency is associated with a CNS malformation syndrome
and urinary tract defects. PLoS Genet 2007; 3: e80
101. Mugford JW, Sipila P, McMahon JA et al. Osr1 expression
demarcates a multi-potent population of intermediate
396 | S. Jain and F. Chen
D
ow
nloaded from
 https://academ
ic.oup.com
/ckj/article-abstract/12/3/382/5224972 by W
ashington U
niversity, Law
 School Library user on 15 N
ovem
ber 2019
mesoderm that undergoes progressive restriction to an
Osr1-dependent nephron progenitor compartment within
themammalian kidney. Dev Biol 2008; 324: 88–98
102. James RG, Kamei CN, Wang Q et al. Odd-skipped related 1 is
required for development of the metanephric kidney and
regulates formation and differentiation of kidney precursor
cells. Development. 2006; 133: 2995–3004
103. Wang Q, Lan Y, Cho ES et al. Odd-skipped related 1 (Odd1) is
an essential regulator of heart and urogenital development.
Dev Biol 2005; 288: 582–594
104. Murawski IJ, Myburgh DB, Favor J et al. Vesico-ureteric re-
flux and urinary tract development in the Pax2 1Neuþ/
mouse.Am J Physiol Renal Physiol 2007; 293: F1736–F1745
105. Sanyanusin P, Schimmenti LA, McNoe LA et al. Mutation of
the PAX2 gene in a family with optic nerve colobomas, re-
nal anomalies and vesicoureteral reflux. Nat Genet 1995; 9:
358–364
106. Choi KL, McNoe LA, French MC et al. Absence of PAX2 gene
mutations in patients with primary familial vesicoureteric
reflux. J Med Genet 1998; 35: 338–339
107. Favor J, Sandulache R, Neuhauser-Klaus A et al. The mouse
Pax2(1Neu) mutation is identical to a human PAX2 muta-
tion in a family with renal-coloboma syndrome and results
in developmental defects of the brain, ear, eye, and kidney.
Proc Natl Acad Sci USA 1996; 93: 13870–13875
108. Sanyanusin P, McNoe LA, Sullivan MJ et al. Mutation of
PAX2 in two siblings with renal-coloboma syndrome. Hum
Mol Genet 1995; 4: 2183–2184
109. Keller SA, Jones JM, Boyle A. Kidney and retinal defects
(Krd), a transgene-induced mutation with a deletion of
mouse chromosome 19 that includes the Pax2 locus.
Genomics 1994; 23: 309–320
110. Dressler GR, Wilkinson JE, Rothenpieler UW et al.
Deregulation of Pax-2 expression in transgenic mice gener-
ates severe kidney abnormalities.Nature 1993; 362: 65–67
111. Torres M, Gomez-Pardo E, Dressler GR et al. Pax-2 controls
multiple steps of urogenital development. Development
1995; 121: 4057–4065
112. Schnabel CA, Godin RE, Cleary ML. Pbx1 regulates nephro-
genesis and ureteric branching in the developing kidney.
Dev Biol 2003; 254: 262–276
113. Chang CP, McDill BW, Neilson JR et al. Calcineurin is re-
quired in urinary tract mesenchyme for the development
of the pyeloureteral peristaltic machinery. J Clin Invest 2004;
113: 1051–1058
114. Uetani N, Bertozzi K, Chagnon MJ et al. Maturation of
ureter-bladder connection in mice is controlled by LAR
family receptor protein tyrosine phosphatases. J Clin Invest
2009; 119: 924–935
115. Kong X-T, Deng F-M, Hu P et al. Roles of uroplakins in pla-
que formation, umbrella cell enlargement, and urinary
tract diseases. J Cell Biol 2004; 167: 1195–1204
116. Takahashi N, Lopez MLSS, Cowhig JE et al. Ren1c homozy-
gous null mice are hypotensive and polyuric, but heterozy-
gotes are indistinguishable fromwild-type. J Am Soc Nephrol
2005; 16: 125–132
117. Vega QC, Worby CA, Lechner MS et al. Glial cell line-derived
neurotrophic factor activates the receptor tyrosine kinase
RET and promotes kidneymorphogenesis. Proc Natl Acad Sci
USA 1996; 93: 10657–10661
118. Sainio K, Suvanto P, Davies J et al. Glial-cell-line-derived
neurotrophic factor is required for bud initiation from ure-
teric epithelium. Development 1997; 124: 4077–4087
119. Batourina E, Choi C, Paragas N et al. Distal ureter morpho-
genesis depends on epithelial cell remodeling mediated by
vitamin A and Ret. Nat Genet 2002; 32: 109–115
120. Jain S, Encinas M, Johnson EM Jr et al. Critical and distinct
roles for key RET tyrosine docking sites in renal develop-
ment. Genes Dev 2006; 20: 321–333
121. JijiwaM, Fukuda T, Kawai K et al. A targetingmutation of ty-
rosine 1062 in Ret causes a marked decrease of enteric neu-
rons and renal hypoplasia.Mol Cell Biol 2004; 24: 8026–8036
122. Skinner MA, Safford SD, Reeves JG et al. Renal aplasia in
humans is associated with RET mutations. Am J Hum Genet
2008; 82: 344–351
123. Zhang Z, Quinlan J, Hoy W et al. A common RET variant is
associated with reduced newborn kidney size and function.
J Am Soc Nephrol 2008; 19: 2027–2034
124. Hoshi M, Reginensi A, Joens MS et al. Reciprocal spatiotem-
porally controlled apoptosis regulates Wolffian duct cloaca
fusion. J Am Soc Nephrol 2018; 29: 775–783
125. Yu OH, Murawski IJ, Myburgh DB et al. Overexpression of
RET leads to vesicoureteric reflux in mice. Am J Physiol Renal
Physiol 2004; 287: F1123–F1130
126. Grieshammer U, Le M, Plump AS. SLIT2-mediated ROBO2
signaling restricts kidney induction to a single site. Dev Cell
2004; 6: 709–717
127. Lu W, van Eerde AM, Fan X et al. Disruption of ROBO2 is as-
sociated with urinary tract anomalies and confers risk of
vesicoureteral reflux. Am J Hum Genet 2007; 80: 616–632
128. Bertoli-Avella AM, Conte ML, Punzo F et al. ROBO2 gene var-
iants are associated with familial vesicoureteral reflux.
J Am Soc Nephrol 2008; 19: 825–831
129. Kiefer SM, Ohlemiller KK, Yang J et al. Expression of a trun-
cated Sall1 transcriptional repressor is responsible for
Townes-Brocks syndrome birth defects. Hum Mol Genet
2003; 12: 2221–2227
130. Nishinakamura R, Matsumoto Y, Nakao K et al. Murine ho-
molog of SALL1 is essential for ureteric bud invasion in kid-
ney development. Development 2001; 128: 3105–3115
131. Kohlhase J. SALL1 mutations in Townes-Brocks syndrome
and related disorders. HumMutat 2000; 16: 460–466
132. Ruf RG, Xu P-X, Silvius D et al. SIX1 mutations cause
branchio-oto-renal syndrome by disruption of EYA1-SIX1-
DNA complexes. Proc Natl Acad Sci USA 2004; 101: 8090–8095
133. Xu PX, Zheng W, Huang L et al. Six1 is required for the early
organogenesis of mammalian kidney. Development 2003;
130: 3085–3094
134. Kobayashi A, Valerius MT, Mugford JW et al. Six2 defines
and regulates a multipotent self-renewing nephron pro-
genitor population throughout mammalian kidney devel-
opment. Cell Stem Cell 2008; 3: 169–181
135. Self M, Lagutin OV, Bowling B et al. Six2 is required for sup-
pression of nephrogenesis and progenitor renewal in the
developing kidney. EMBO J 2006; 25: 5214–5228
136. Yu J, Carroll TJ, McMahon AP. Sonic hedgehog regulates
proliferation and differentiation of mesenchymal cells in
the mouse metanephric kidney. Development 2002; 129:
5301–5312
137. Takahashi N, Chernavvsky DR, Gomez RA et al.
Uncompensated polyuria in a mouse model of Bartter’s
syndrome. Proc Natl Acad Sci USA 2000; 97: 5434–5439
138. Oxburgh L, Chu GC, Michael SK et al. TGFb superfamily sig-
nals are required for morphogenesis of the kidney mesen-
chyme progenitor population. Development 2004; 131:
4593–4605
Developmental pathology CAKUT | 397
D
ow
nloaded from
 https://academ
ic.oup.com
/ckj/article-abstract/12/3/382/5224972 by W
ashington U
niversity, Law
 School Library user on 15 N
ovem
ber 2019
139. Tripathi P, Wang Y, Casey AM, et al. Absence of canonical
Smad signaling in ureteral and bladder mesenchyme
causes ureteropelvic junction obstruction. J Am Soc Nephrol
2012; 23: 618–628
140. Basson MA, Akbulut S, Watson-Johnson J et al. Sprouty1 is a
critical regulator of GDNF/RET-mediated kidney induction.
Dev Cell 2005; 8: 229–239
141. Chi L, Zhang S, Lin Y et al. Sprouty proteins regulate ureteric
branching by coordinating reciprocal epithelial Wnt11,
mesenchymal Gdnf and stromal Fgf7 signalling during kid-
ney development. Development 2004; 131: 3345–3356
142. Airik R, BussenM, SinghMK et al. Tbx18 regulates the devel-
opment of the ureteral mesenchyme. J Clin Invest 2006; 116:
663–674
143. Lo SH, Yu QC, Degenstein L et al. Progressive kidney degen-
eration in mice lacking tensin. J Cell Biol 1997; 136:
1349–1361
144. Caubit X, Lye CM, Martin E et al. Teashirt 3 is necessary for
ureteral smooth muscle differentiation downstream of
SHH and BMP4. Development 2008; 135: 3301–3310
145. Hu P, Deng F-M, Liang F-X et al. Ablation of uroplakin III
gene results in small urothelial plaques, urothelial leakage,
and vesicoureteral reflux. J Cell Biol 2000; 151: 961–972
146. Kispert A, Vainio S, McMahon AP. Wnt-4 is a mesenchymal
signal for epithelial transformation of metanephric mesen-
chyme in the developing kidney. Development 1998; 125:
4225–4234
147. Stark K, Vainio S, Vassileva G et al. Epithelial transforma-
tion of metanephric mesenchyme in the developing kidney
regulated byWnt-4.Nature 1994; 372: 679–683
148. Carroll TJ, Park JS, Hayashi S et al. Wnt9b plays a central role
in the regulation of mesenchymal to epithelial transitions
underlying organogenesis of the mammalian urogenital
system. Dev Cell 2005; 9: 283–292
149. Majumdar A, Vainio S, Kispert A et al. Wnt11 and Ret/Gdnf
pathways cooperate in regulating ureteric branching dur-
ing metanephric kidney development. Development 2003;
130: 3175–3185
150. Nicolaou N, Renkema KY, Bongers EM et al. Genetic, envi-
ronmental, and epigenetic factors involved in CAKUT. Nat
Rev Nephrol 2015; 11: 720–731
151. Rodriguez MM. Congenital anomalies of the kidney and the
urinary tract (CAKUT). Fetal Pediatr Pathol 2014; 33: 293–320
152. Vivante A, Kohl S, Hwang DY et al. Single-gene causes of
congenital anomalies of the kidney and urinary tract
(CAKUT) in humans. Pediatr Nephrol 2014; 29: 695–704
153. Madariaga L, Morinie`re V, Jeanpierre C et al. Severe prenatal
renal anomalies associated with mutations in HNF1B or
PAX2 genes. Clin J Am Soc Nephrol 2013; 8: 1179–1187
154. Davis TK, Hoshi M, Jain S. To bud or not to bud: the RET per-
spective in CAKUT. Pediatr Nephrol 2014; 29: 597–608
155. Allison SJ. Basic research: Ret signaling reveals insights
into the pathogenesis of CAKUT. Nat Rev Nephrol 2012; 8:
432
156. Hwang D-Y, Dworschak GC, Kohl S et al. Mutations in 12
known dominant disease-causing genes clarify many con-
genital anomalies of the kidney and urinary tract. Kidney Int
2014; 85: 1429–1433
157. Harshman LA, Brophy PD. PAX2 in human kidney malfor-
mations and disease. Pediatr Nephrol 2012; 27: 1265–1275
158. Kohl S, Hwang D-Y, Dworschak GC et al. Mild recessive
mutations in six Fraser syndrome-related genes cause iso-
lated congenital anomalies of the kidney and urinary tract.
J Am Soc Nephrol 2014; 25: 1917–1922
159. Sanna-Cherchi S, Kiryluk K, Burgess KE et al. Copy-number
disorders are a common cause of congenital kidneymalfor-
mations. Am J Hum Genet 2012; 91: 987–997
160. Verbitsky M, Sanna-Cherchi S, Fasel DA et al. Genomic
imbalances in pediatric patients with chronic kidney dis-
ease. J Clin Invest 2015; 125: 2171–2178
161. Westland R, Verbitsky M, Vukojevic K et al. Copy number
variation analysis identifies novel CAKUT candidate genes
in children with a solitary functioning kidney. Kidney Int
2015; 88: 1402–1410
162. Whitten SM, Wilcox DT. Duplex systems. Prenat Diagn 2001;
21: 952–957
163. N’Guessan G, Stephens FD. Supernumerary kidney. J Urol
1983; 130: 649–653
164. Haddad FS, Griffin EE. II The Weigert-Meyer law demysti-
fied. J Islamic Med Assoc 1996; 28: 16–19
165. Kerecuk L, Schreuder MF, Woolf AS. Renal tract malforma-
tions: perspectives for nephrologists. Nat Clin Pract Nephrol
2008; 4: 312–325
166. Potter EL. Facial characteristics of infants with bilateral re-
nal agenesis. Am J Obstet Gynecol 1946; 51: 885–888
167. Winyard P, Chitty LS. Dysplastic kidneys. Semin Fetal
Neonatal Med 2008; 13: 142–151
168. Hiraoka M, Tsukahara H, Ohshima Y et al. Renal aplasia is
the predominant cause of congenital solitary kidneys.
Kidney Int 2002; 61: 1840–1844
169. Mansoor O, Chandar J, Rodriguez MM et al. Long-term risk
of chronic kidney disease in unilateral multicystic dysplas-
tic kidney. Pediatr Nephrol 2011; 26: 597–603
170. Grattan-Smith JD, Jones RA, Little S et al. Bilateral congeni-
tal midureteric strictures associated with multicystic dys-
plastic kidney and hydronephrosis: evaluation with MR
urography. Pediatr Radiol 2011; 41: 117–120
171. Singh JK, Kanojia RP, Narasimhan KL. Multicystic dysplastic
kidney in children — a need for conservative and long term
approach. Indian J Pediatr 2009; 76: 809–812
172. Schreuder MF, Westland R, van Wijk JA. Unilateral multi-
cystic dysplastic kidney: a meta-analysis of observational
studies on the incidence, associated urinary tract malfor-
mations and the contralateral kidney. Nephrol Dial
Transplant 2009; 24: 1810–1818
173. Kiyak A, Yilmaz A, Turhan P et al. Unilateral multicystic
dysplastic kidney: single-center experience. Pediatr Nephrol
2009; 24: 99–104
174. Hains DS, Bates CM, Ingraham S et al. Management and eti-
ology of the unilateral multicystic dysplastic kidney: a re-
view. Pediatr Nephrol 2009; 24: 233–241
175. van den Bosch CMA, van Wijk JAE, Beckers GMA et al.
Urological and nephrological findings of renal ectopia.
J Urol 2010; 183: 1574–1578
176. Stephens FD, Smith ED, Hutson JM. Congenital Anomalies of
the Kidney, Urinary and Genital Tracts: London: Martin Dunitz,
2002
177. Parvex P, Pippi-Salle JL, Goodyer PR. Rapid loss of renal pa-
renchyma after acute obstruction. Pediatr Nephrol 2001; 16:
1076–1079
178. Ercolani M, Sahota A, Schuler C et al. Bladder outlet ob-
struction in male cystinuria mice. Int Urol Nephrol 2010; 42:
57–63
179. Gambaro G, Favaro S, D’Angelo A. Risk for renal failure in
nephrolithiasis. Am J Kidney Dis 2001; 37: 233–243
180. Chevalier RL, Thornhill BA, Forbes MS et al. Mechanisms of
renal injury and progression of renal disease in congenital
obstructive nephropathy. Pediatr Nephrol 2010; 25: 687–697
398 | S. Jain and F. Chen
D
ow
nloaded from
 https://academ
ic.oup.com
/ckj/article-abstract/12/3/382/5224972 by W
ashington U
niversity, Law
 School Library user on 15 N
ovem
ber 2019
181. Ingraham SE, McHugh KM. Current perspectives on con-
genital obstructive nephropathy. Pediatr Nephrol 2011; 26:
1453–1461
182. Liapis H. Biology of congenital obstructive nephropathy.
Nephron Exp Nephrol 2003; 93: e87–e91
183. Duffield JS. Epithelial to mesenchymal transition in injury
of solid organs: fact or artifact? Gastroenterology 2010; 139:
1081–1083
184. Humphreys BD, Lin SL, Kobayashi A et al. Fate tracing
reveals the pericyte and not epithelial origin of myofibro-
blasts in kidney fibrosis. Am J Pathol 2010; 176: 85–97
185. LeBleu VS, Taduri G, O’Connell J et al. Origin and function of
myofibroblasts in kidney fibrosis. Nat Med 2013; 19:
1047–1053
186. Klein J, Gonzalez J, Miravete M et al. Congenital ureteropel-
vic junction obstruction: human disease and animal mod-
els. Int J Exp Pathol 2011; 92: 168–192
187. Yiee JH, Johnson-Welch S, Baker LA et al. Histologic differ-
ences between extrinsic and intrinsic ureteropelvic junc-
tion obstruction. Urology 2010; 76: 181–184
188. Murawski IJ, Gupta IR. Vesicoureteric reflux and renal mal-
formations: a developmental problem. Clin Genet 2006; 69:
105–117
189. Hensle TW, Grogg AL. Part 1: vesicoureteral reflux treat-
ment: the past, present, and future. Curr Med Res Opin 2007;
23: S1–S5
190. Gargollo PC, Diamond DA. Therapy insight: what nephrolo-
gists need to know about primary vesicoureteral reflux. Nat
Clin Pract Nephrol 2007; 3: 551–563
191. Eccles MR, Jacobs GH. The genetics of primary vesico-
ureteric reflux. Ann Acad Med 2000; 29: 337–345
192. Mak RH, Kuo HJ. Primary ureteral reflux: emerging insights
from molecular and genetic studies. Curr Opin Pediatr 2003;
15: 181–185
193. Lama G, Russo M, De Rosa E et al. Primary vesicoureteric re-
flux and renal damage in the first year of life. Pediatr Nephrol
2000; 15: 205–210
194. Williams G, Fletcher JT, Alexander SI et al. Vesicoureteral
reflux. J Am Soc Nephrol 2008; 19: 847–862
195. Puri P, Kumar R. Endoscopic correction of vesicoureteral re-
flux secondary to posterior urethral valves. J Urol 1996; 156:
680–682
196. Hassan JM, Pope JC, Brock JW et al. Vesicoureteral reflux in
patients with posterior urethral valves. J Urol 2003; 170:
1677–1680
197. Upadhyay J, Bolduc S, Braga L et al. Impact of prenatal diag-
nosis on the morbidity associated with ureterocele man-
agement. J Urol 2002; 167: 2560–2565
198. Tullus K. Vesicoureteric reflux in children. Lancet 2015; 385:
371–379
199. Coplen DE, Duckett JW. The modern approach to uretero-
celes. J Urol 1995; 153: 166–171
200. Avritscher R, Madoff DC, Ramirez PT et al. Fistulas of the
lower urinary tract: percutaneous approaches for the man-
agement of a difficult clinical entity. Radiographics 2004; 24:
S217–S236
201. Yu NC, Raman SS, Patel M et al. Fistulas of the genitouri-
nary tract: a radiologic review. Radiographics 2004; 24:
1331–1352
202. Baird DR, Orangio GR, Lucas GW. A complex ileovaginal fis-
tula with associated obstructive uropathy in a patient with
Crohn’s disease: technical considerations and review of the
literature. South Med J 1991; 84: 389–391
203. Dwyer PL, Rosamilia A. Congenital urogenital anomalies
that are associated with the persistence of Gartner’s duct: a
review. Am J Obstet Gynecol 2006; 195: 354–359
204. Krishnan A, de Souza A, Konijeti R et al. The anatomy and
embryology of posterior urethral valves. J Urol 2006; 175:
1214–1220
205. Hodges SJ, Patel B, McLorie G et al. Posterior urethral valves.
ScientificWorldJournal 2009; 9: 1119–1126
206. Lopez Pereira P, Martinez Urrutia MJ, Jaureguizar E. Initial
and long-term management of posterior urethral valves.
World J Urol 2004; 22: 418–424
207. Yohannes P, Hanna M. Current trends in the management
of posterior urethral valves in the pediatric population.
Urology 2002; 60: 947–953
208. Agarwal S. Urethral valves. BJU Int 1999; 84: 570–578
Developmental pathology CAKUT | 399
D
ow
nloaded from
 https://academ
ic.oup.com
/ckj/article-abstract/12/3/382/5224972 by W
ashington U
niversity, Law
 School Library user on 15 N
ovem
ber 2019
